Related Experiment Videos
Ovarial cancer: best timing and applications of debulking surgery
S Pecorelli1, F Odicino, G Favalli
1Spedali Civili, University of Brescia, Department of Obstetrics and Gynecology, Italy.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The MEATIC technique: Enhancing ureteral meatus visualization during pediatric cystoscopy using iodinated contrast.
Journal of pediatric urology·2026
Moderate and severe fetal pyelectasis: Correlation between prenatal aspects and postnatal outcome.
Journal of neonatal-perinatal medicine·2019
Clinical and prognostic value of 18F-FDG PET/CT in recurrent endometrial carcinoma.
Revista espanola de medicina nuclear e imagen molecular·2018
Role of 18F-FDG PET/CT in restaging and follow-up of patients with uterine sarcomas.
Revista espanola de medicina nuclear e imagen molecular·2018
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026